% Expired Patents = 60.0

EPO Patents = 1

Trademarks = 3

Forward Citations = 14

Loading Chart...

4 inventors (with patents filed for the assignee):

Annette Tobia (5 out of 8 patents)

Francis Kappler (3 out of 7 patents)

Lisa Laury-Kleintop (1 out of 4 patents)

4. Arturo Bravo Nuevo (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 9555012 - Methods for maintaining or improving health, well-being and/or a physiological function in a subject (2017-01-31),

2. 9446007 - Methods for maintaining or improving health, well-being and/or a physiological function in a subject (2016-09-20),

3. 7749503 - 3-deoxyglucosone and skin (2010-07-06),

4. 7671019 - 3-deoxyglucosone and skin (2010-03-02),

5. 7622117 - 3-deoxyglucosone and skin (2009-11-24),

Company Overview

Dynamis Therapeutics, Inc. is a biotechnology company focused on developing novel therapies for neurodegenerative diseases. Our innovative approach utilizes cutting-edge technology to target specific pathways involved in disease progression. With a team of experienced scientists and experts, we are dedicated to advancing treatments that improve the quality of life for patients suffering from these debilitating conditions.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

5 Patents

#4 in Jenkintown, PA

#1,872 in Pennsylvania

#51,644 in US

Jenkintown, PA, United States of America

Dynamis Therapeutics, Inc.

Forward Citations = 14

4 inventors:

Annette Tobia (5 out of 8 patents)

Francis Kappler (3 out of 7 patents)

Lisa Laury-Kleintop (1 out of 4 patents)

4. Arturo Bravo Nuevo (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Dynamis Therapeutics, Inc.. Retrieved from https://idiyas.com/company/dynamis-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]